Page last updated: 2024-08-22

lutetium and alovudine

lutetium has been researched along with alovudine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kjaer, A; Madsen, J; Persson, M; Ploug, M; Rasmussen, P	1

Other Studies

1 other study(ies) available for lutetium and alovudine

Article	Year
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts. Nuclear medicine and biology, 2012, Volume: 39, Issue:7 Topics: Animals; Beta Particles; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Female; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Lutetium; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Oligopeptides; Positron-Emission Tomography; Radioisotopes; Receptors, Urokinase Plasminogen Activator; Substrate Specificity	2012

Article

Year

New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.

Nuclear medicine and biology, 2012, Volume: 39, Issue:7

Topics: Animals; Beta Particles; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Female; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Lutetium; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Oligopeptides; Positron-Emission Tomography; Radioisotopes; Receptors, Urokinase Plasminogen Activator; Substrate Specificity

2012